| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 14, 2021 | Dec 16, 2021 | ARVINAS, INC. | Director | Sell | 15.0 | -355,705 | -65.70% | ✗ | $23.8M |
| Nov 10, 2021 | Nov 15, 2021 | ARVINAS, INC. | Director | Sell | 15.0 | -134,310 | -19.88% | ✗ | $11.5M |
| Nov 5, 2021 | Nov 9, 2021 | ARVINAS, INC. | Director | Sell | 15.0 | -172,079 | -20.30% | ✗ | $16M |
| Dec 18, 2020 | Dec 21, 2020 | ARVINAS, INC. | Director | Buy | 100.0 | +142,857 | 21.01% | ✗ | $10M |
| Mar 3, 2020 | Mar 13, 2020 | Passage BIO, Inc. | Director | Buy | 100.0 | +552,800 | 26.75% | ✗ | $10M |
| Mar 3, 2020 | Mar 3, 2020 | Passage BIO, Inc. | Director | Buy | 95.0 | +2,800 | 100.00% | ✗ | $50.4K |
| Nov 12, 2019 | Nov 14, 2019 | ARVINAS, INC. | Director | Buy | 100.0 | +680,000 | 100.00% | ✗ | $15M |
| Oct 1, 2018 | Oct 3, 2018 | ARVINAS, INC. | Director | Buy | 100.0 | +1,000,000 | 77.94% | ✗ | $16M |
| May 30, 2018 | May 31, 2018 | Iterum Therapeutics plc | 10% Owner | Buy | 100.0 | +662,677 | 83.50% | ✗ | $8.6M |
| Apr 3, 2018 | Apr 3, 2018 | Cogent Biosciences, Inc. | Director | Buy | 100.0 | +550,000 | 44.16% | ✗ | $6.6M |
| Oct 25, 2016 | Oct 25, 2016 | iRhythm Technologies, Inc. | 10% Owner | Buy | 85.0 | +25,000 | 1.46% | ✗ | $425K |
| Mar 24, 2015 | Mar 26, 2015 | MEI Pharma, Inc. | 10% Owner | Sell | 17.5 | -1,601,390 | -100.00% | ✗ | $3.2M |
| Dec 8, 2014 | Dec 10, 2014 | MEI Pharma, Inc. | 10% Owner | Sell | 20.0 | -79,085 | -4.71% | ✗ | $475.6K |
| Nov 21, 2013 | Nov 25, 2013 | MEI Pharma, Inc. | 10% Owner | Sell | 17.5 | -365,000 | -17.84% | ✗ | $3M |